Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Shionogi to Launch MS Contin in Small Packages
June 4, 2001
- COPRORATE ROUNDUP NEWS IN BRIEF -2-
June 4, 2001
- Takeda to Increase OTC Sales to \100 Bil. in 2005
June 4, 2001
- COPRORATE ROUNDUP NEWS IN BRIEF -3-
June 4, 2001
- Efco, Kyuyukai to Merge in Fall
June 4, 2001
- Continuing Growth by Focusing on Specialty Pharmaceuticals: Mr Pyott of Allergan
June 4, 2001
- Takiya Shoji, Drux to Merge in August
June 4, 2001
- Listing of 14 Active Ingredients Including Radicut, Zyprexa Approved
June 4, 2001
- Taisho Terminates Business with Daikoku Group
June 4, 2001
- Peak-time Sales of Radicut, Zyprexa Expected to Top \10 Bil.
June 4, 2001
- NEW PRODUCTS NEWS IN BRIEF
June 4, 2001
- Chuikyo to Review NHI Pricing Rule
June 4, 2001
- WORLD NEWS IN BRIEF
June 4, 2001
- EMA Demands Acceptance of "Moth-eaten Applications"
June 4, 2001
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
June 4, 2001
- Pricing Organization Accepts Eli Lilly Japan's Objection
June 4, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
June 4, 2001
- REGULATORY NEWS IN BRIEF
June 4, 2001
- DIAGNOSTIC NEWS IN BRIEF
June 4, 2001
- Kowa Licenses Antidiabetic Drug from Roche
June 4, 2001
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…